PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Neuropsychopharmacol
Autors principals: Woo, Young Sup, Park, Joo Eon, Kim, Do-Hoon, Sohn, Inki, Hwang, Tae-Yeon, Park, Young-Min, Jon, Duk-In, Jeong, Jong-Hyun, Bahk, Won-Myong, Woo, Y. S., Jeong, J. H., Bahk, W. M., Sohn, I. K., Park, J. E., Kim, D. H., Hwang, T. Y., Park, Y. M., Jon, D. I.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5616358/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyw041.423
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars